Exhibit A

JOINT FILING AGREEMENT

The undersigned agree that this Schedule 13G Amendment No. 1 dated May 15, 2025 relating to the Common Stock, $0.0001 par value, of Nektar Therapeutics shall be filed on behalf of the undersigned.

SAMLYN CAPITAL, LLC
By:	Samlyn, LP, its sole member
By:	Samlyn GP, LLC, its general partner
By:	/s/ Robert Pohly
	Name:  Robert Pohly
	Title:  Managing Member
SAMLYN, LP
By:	Samlyn GP, LLC, its general partner
By:	/s/ Robert Pohly
	Name:  Robert Pohly
	Title:  Managing Member
ROBERT POHLY
By:	/s/ Robert Pohly